These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3976516)

  • 21. Hemodynamic effects of celiprolol in essential hypertension.
    Frohlich ED; Ketelhut R; Kaesser UR; Losem CJ; Messerli FH
    Am J Cardiol; 1991 Aug; 68(5):509-14. PubMed ID: 1678580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion.
    Wouters PF; Marcus MA; Van Aken HK; van de Velde M; Miserez M; Deruyter HA; Mignolet K; Flameng W
    Eur J Anaesthesiol; 1994 Sep; 11(5):381-90. PubMed ID: 7988582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular effects of isradipine in essential hypertension.
    Grossman E; Messerli FH; Oren S; Nunez B; Garavaglia GE
    Am J Cardiol; 1991 Jul; 68(1):65-70. PubMed ID: 1829320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic effects of the multiple action antihypertensive drug urapidil.
    Mancia G
    Drugs; 1990; 40 Suppl 4():14-20; discussion 28-30. PubMed ID: 2092964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Adnot S; Andrivet P; Piquet J; Brun-Buisson C; Rauss A; Bignon J; Lemaire F
    Am Rev Respir Dis; 1988 May; 137(5):1068-74. PubMed ID: 3143277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of urapidil in the treatment of acute hypertension].
    Lehot JJ; Bonnefoy E; Dalmas JP; Filley S; Bastien O; George M
    Cah Anesthesiol; 1995; 43(1):67-76. PubMed ID: 7671060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular and metabolic profile during intervention with urapidil in humans.
    Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
    Hypertension; 1985; 7(6 Pt 1):963-71. PubMed ID: 3908316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of the hypertensive crisis with urapidil. Various effects on patients with or without coronary disease].
    Zähringer J; Klepzig M; Greif J; Ludwig B; Strauer B
    Fortschr Med; 1984 Jun; 102(22):624-8. PubMed ID: 6469170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function].
    Wambach G; Godehardt E; Lang R; Haerlin R; Meurer KA
    Arzneimittelforschung; 1987 Aug; 37(8):960-4. PubMed ID: 3675693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urapidil. A reappraisal of its use in the management of hypertension.
    Dooley M; Goa KL
    Drugs; 1998 Nov; 56(5):929-55. PubMed ID: 9829161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
    Ando K; Noda H; Ogata E; Fujita T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension.
    Grossman E; Oren S; Garavaglia GE; Messerli FH; Frohlich ED
    Circulation; 1988 Dec; 78(6):1394-400. PubMed ID: 3191594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic changes and left ventricular function in patients with hypertension during an acute trial of urapidil].
    Sirakova V; Penkov N; Penev A
    Vutr Boles; 1988; 27(5):20-3. PubMed ID: 3062899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of urapidil in the treatment of arterial hypertension].
    Ol'binskaia LI; Vertkin AL; Gogin EE; Zadionchenko VS; Martynov AI; Martynov IV; Kolassa N; Man int Vel'd AI; Sidorenko BA; Belova EV
    Kardiologiia; 1992 Apr; 32(4):99-111. PubMed ID: 1357221
    [No Abstract]   [Full Text] [Related]  

  • 36. Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.
    Ventura HO; Messerli FH; Frohlich ED; Kobrin I; Oigman W; Dunn FG; Carey RM
    Circulation; 1984 Jun; 69(6):1142-5. PubMed ID: 6143625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension.
    Frohlich ED; McLoughlin MJ; Losem CJ; Ketelhut R; Messerli FH
    Am J Cardiol; 1991 Nov; 68(13):1346-50. PubMed ID: 1951124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urapidil reduces elevated pulmonary vascular resistance in patients before heart transplantation.
    Zink M; Gombotz H; Wasler A; Grasser B; Rehak P; Metzler H
    J Heart Lung Transplant; 2002 Mar; 21(3):347-53. PubMed ID: 11897523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil.
    Ghione S; Genovesi-Ebert A; Marabotti C; Spinazzi A; Noseda A
    Blood Press Suppl; 1994; 4():25-30. PubMed ID: 7804509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Metabolic and cardiovascular profile in antihypertensive treatment with urapidil].
    Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
    Therapie; 1990; 45 Suppl 2():219-27. PubMed ID: 2187268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.